Cells of Bordetella pertussis BP353, a nonfimbriated Eldering serotype 1.3 strain, were used as an immunogen to produce three monoclonal antibodies, BPE3, BPD8, and BPE8, that agglutinated the immunizing cells, as well as certain other nonfimbriated and fimbriated serotype 3-containing B. pertussis strains. The antibodies did not agglutinate serotype 1 or nontypable B. pertussis cells. These monoclonal antibodies specifically detected a 69-kilodalton (kDa) band on Western blots (immunoblots) containing whole B. pertussis cell lysates of Eldering agglutinogen serotypes 1.3, 1.3.6, 1.2.3.4, and 1.2.3.4.6. This 69-kDa antigen was released from the bacteria by cell incubation for 60 min at 60°C, and it was purified by affinity chromatography with a BPE3-agarose affinity matrix. Purified material was used to produce a polyclonal antiserum that agglutinated all nonfimbriated and fimbriated B. pertussis cells containing serotype 3 agglutinogen. Immunogold electron microscopy and indirect immunofluorescence studies demonstrated that it is an outer membrane constituent but nonfimbrial in appearance. BPE3 did not detect purified fimbriae on Western blots, and antibodies to these fimbriae did not bind to the 69-kDa component. Although B. bronchiseptica and B. parapertussis cells were not agglutinated by the monoclonal antibodies, antigenically similar proteins were detected in extracts of the bacteria. These results identify the 69-kDa protein as a nonfimbrial agglutinogen present on all virulent strains of B. pertussis. The monoclonal antibodies described here should be useful for further studies on the structure and function of this protein.
Serotype markers for Bordetella pertussis have historically been defined by the ability of strain-specific polyclonal antisera to agglutinate the bacteria. Andersen first identified five distinct agglutinogen factors (1) , and subsequently Eldering et al. added agglutinogen factor 6 (6) . The U.S. Reference Factor 1 to 6 antisera prepared by Eldering et al. (6) and three monospecific polyclonal antisera (Factors 1 to 3) produced by Preston (23) have been used to identify the serotypes of human isolates and to distinguish B. pertussis from the closely related species B. bronchiseptica and B. parapertussis (5, 14, 25) . The prevalence of certain serotypes following outbreaks of whooping cough has been noted (8, 25) , and there is some evidence that serum agglutinin titers of human vaccinees correlate with clinical protection from pertussis (16) . Therefore, the agglutinogen factors present on B. pertussis may contribute to the formulation of better-defined protective vaccines.
Some of these agglutinogen factors have been defined, at least in part, at the molecular level. The expression of lipooligosaccharide A by B. pertussis cells is correlated with the presence of the serotype 1 agglutinogen factor (12) , and a fimbrial agglutinogen present on serotype 2-containing cells has been purified and well characterized (3, 9, 26, 31) .
Fimbriae isolated from strains agglutinated by U.S. Reference Factor 6 antiserum (type 6 fimbriae) and Preston agglutinogen 3 antiserum (type 3 fimbriae) appear to be antigenically identical (4, 9, 19) . The agglutinogens recognized by U.S. Reference Factor 3 antiserum have not been well characterized.
To identify agglutinogens of B. pertussis, we have produced a number of monoclonal antibodies that agglutinate serotype-specific strains. Monoclonal antibodies that agglutinate B. pertussis cells containing serotype 1 agglutinogen were found to be uniquely reactive with lipooligosaccharide A (12) . Other monoclonal antibodies have been identified which recognize the serotype 2 and 6 fimbriae of B. pertussis (11) . In this study, monoclonal antibodies were used to characterize a 69-kilodalton (kDa) nonfimbrial outer membrane protein found on B. pertussis cells agglutinated by U.S. Reference Factor 3 antiserum. This protein is expressed by virulent strains of B. pertussis and is antigenically identical to a protein previously correlated with the adenylate cyclase activity of Bordetella species (20) .
MATERIALS AND METHODS
Microorganisms. Cells of Bordetella species were cultured on plates of Bordet-Gengou medium (Difco Laboratories, Detroit, Mich.) containing 15% defibrinated sheep blood, and growth was continued in liquid Cohen-Wheeler medium with constant agitation. Modified Stainer-Scholte medium was used for the liquid culture of B. pertussis 114 and 432. A detailed description of the bacterial growth conditions is provided elsewhere (4, 32) . The bacteria were used for protein purification as described below or fixed in 0.2% formaldehyde and serotyped by the microagglutination assay (15) with U.S. Reference Factor 1 to 6 antisera (Eldering agglutinogen 1 to 6 polyclonal antisera) (6) . The transposon Tn5 insertion mutants of B. pertussis used in this study (28, 29) buffer, the extract was applied to a column of fetuinSepharose 4B (10-ml column volume) to remove pertussis toxin. The flow-through material was chromatographed on a 10-ml column of BPE3 immunoglobulin linked to agarose (Reacti-gel 6X; Pierce Chemical Co., Rockford, Ill.) in the same buffer. The column was washed with 0.5 M NaCl containing 0.5% Zwittergent 3-14 (Calbiochem-Behring, La Jolla, Calif.), and the bound protein was eluted with 6 M urea. The purity of the eluted fractions was assessed by SDS-PAGE, followed by silver staining and Western blot analysis.
Purified material was used to produce polyclonal antisera by immunizing five mice subcutaneously with 20 ,ug of protein per mouse in Freund complete adjuvant, followed in 4 weeks by a secondary injection with incomplete adjuvant. The mice were bled 7 days after the second injection, the sera were pooled, and agglutination tests were performed after nonspecific agglutination was reduced by adsorption of the sera with 25% kaolin (31) . Mouse sera obtained prior to immunization were negative in the agglutination assays.
Immunogold electron microscopy and indirect immunofluorescence. Formaldehyde-fixed B. pertussis cells (2 x 1010) were washed with PBS containing 0.5% bovine serum albumin and incubated with 100 ,ug of immunoglobulin per ml for 1 h at 25°C. Bacteria were washed twice and incubated with a 1:2 dilution of gold-conjugated goat anti-mouse immunoglobulin (10 nm; Boehringer Mannheim Biochemicals, Indianapolis, Ind.) for an additional hour and then washed three times with PBS. Samples were fixed with 1% glutaraldehyde in PBS for 30 min at room temperature, washed three times with PBS, postfixed with 2% osmium tetroxide for 30 rmin, serially dehydrated in alcohol, and embedded in an EponAraldite resin mixture. Thin sections were cut on a Reichert Ultracut E with a diamond knife and stained with Reynolds lead citrate and 5% uranyl acetate. Samples were observed with a Philips EM400HM electron microscope at 80 kV at a magnification of x 30,000 with a liquid N2 anticontamination device routinely in use.
For indirect immunofluorescence assays, 20 ,ul of a formaldehyde-fixed suspension of bacteria was heat dried on a glass cover slip and washed with PBS. The cells were incubated with 25 ,ug of purified immunoglobulin per ml for (Fig. 1A, lanes 1 to 3,  and B, lane 1) . This band, at about 69 kDa, was present in all strains containing serotype 3 agglutinogen, including those not agglutinated by the monoclonal antibody, such as strains 150 (Fig. 1A, lane 2) and 114 (Fig. 1A, lane 3) . No reactivity was observed on immunoblots containing cell lysates of serotype 1 or avirulent strains of B. pertussis (Fig. 1B, lanes  2 and 3) or other gram-negative organisms (data not shown). The two immunoglobulin Gl monoclonal antibodies, BPD8 and BPE8, also reacted with the 69-kDa band by Western blot analysis, but much greater amounts of antibody were required for detection. U.S. Reference Factor 3 antiserum (Eldering agglutinogen 3 polyclonal antiserum) detected a 69-kDa band on identical immunoblots containing B. pertussis cell lysates in a pattern consistent with that of monoclonal antibody BPE3 (Fig. 1A and B, lanes 4 to 6) . This polyclonal antiserum was also reactive with a number of other heterogeneous bands on these Western blots.
Purification of the 69-kDa antigen and production of an agglutinating polyclonal antiserum. B. pertussis BP353 cells were incubated for 60 min at 60°C in PBS, and the 69-kDa component that was detached from the bacteria was assessed by SDS-PAGE (Fig. 2A, lane 1) and immunoblotting (Fig. 2B, lane 4) . This material was chromatographed on a BPE3-agarose affinity matrix, and the 69-kDa antigen was specifically eluted from the column with 6 M urea ( Fig. 2A,  lane 3, and B, lane 6) . The 69-kDa antigen occasionally appeared as a doublet on SDS-PAGE (Fig. 2) . Reactivity of BPE3 with the purified 69-kDa band was substantially diminished after treatment of the blotted antigen with 5 ,ug of trypsin per ml for 10 min at 35°C but not after treatment with periodate (data not shown).
Mice were immunized with the affinity-purified 69-kDa material, and the polyclonal antiserum obtained was tested 1 for its ability to agglutinate serotype-specific strains of B. pertussis ( Table 1 ). The pooled mouse serum agglutinated all of the strains tested except serotype 1 and nontypable strains. As with monoclonal antibodies BPE3, BPD8, and BPE8, the agglutination titers were greatest with serotype 1.3 B. pertussis cells. Also, like the monoclonal antibodies, this polyclonal antiserum specifically detected a 69-kDa band on Western blots containing BP353 cell lysates (data not shown).
Identification of the 69-kDa antigen as a nonfimbrial component of the outer membrane. Immunogold electron microscopy was used to compare the distribution of the 69-kDa antigen and type 6 fimbriae on B. pertussis cells, with gold-labeled secondary antibodies used to visualize the binding of primary monoclonal antibodies. Following incubation of BP353 (Fig. 3A) or 432 (Fig. 3B ) cells with the anti-69-kDa antibody BPD8, numerous gold particles were observed in close apposition to their outer membranes. Frequently, small clusters of two to five gold particles were observed, suggesting an oligomeric arrangement or local concentrations of the antigen. Different results were obtained with anti-fimbrial antibody BPC10. This antibody did not label BP353 cells (Fig. 3C) , and with fimbriated 432 cells its labeling pattern included characteristic constellations of gold particles extending to considerable distances from the bacterial surface (Fig. 3D, arrow) . These constellations are consistent with multiple labeling of fimbriae that extend from the bacterial surface while remaining within the plane of the section.
These results and the fact that fimbriae were not observed on cells of the immunizing strain, BP353, by electron microscopy of either negatively stained or rotary shadowed specimens (data not shown) indicate that the 69-kDa antigen is not a fimbrial protein. A. -. (lanes 1, 4, and 7) , 69-kDa protein (lanes 2, 5, and 8), and type 6 fimbriae (lanes 3, 6, and 9) were detected with monoclonal antibody BPF2 (A), BPE3 (B), or BPC10 (C). Molecular mass markers (in kilodaltons) are listed to the left.
sion that the 69-kDa antigen is not a fimbrial agglutinogen, the reactivity of BPE3 and the monoclonal antibodies to type 2 (BPF2) and 6 (BPC10) fimbriae were compared by using Western blots containing purified proteins. On immunoblots containing SDS-treated, nonboiled, purified type 2 fimbriae, 69-kDa protein, and type 6 fimbriae, anti-type 2 fimbrial monoclonal antibody BPF2 detected bands only in the lane containing type 2 fimbriae (Fig. 4A, lane 1) . This appearance of uniformly repeating oligomeric bands or laddering is characteristic of fimbriae detected by this method (11) . BPE3 detected only the 69-kDa band and did not show the laddering effect (Fig. 4B, lane 5) . In contrast, the laddering pattern was apparent in the lane containing purified type 6 fimbriae on the filter reacted with anti-type 6 fimbrial monoclonal antibody BPC10 (Fig. 4C, lane 9) . With these monoclonal antibodies no antigenic cross-reactivity was observed.
Recognition of an antigenically similar protein on B. bronchiseptica and B. parapertussis. Although B. bronchiseptica and B. parapertussis strains were not agglutinated by BPE3, the monoclonal antibody did detect a band(s) that migrated slightly slower than the B. pertussis 69-kDa band (Fig. 5A , lane 1) on Western blots containing cell extracts of B. bronchiseptica 058 (Fig. 5A, lane 2) and B. parapertussis 497 (Fig. 5A, lane 3) . These results suggest that the 69-kDa antigen is similar to an outer membrane protein first identified on B. bronchiseptica with monoclonal antibody BB05 (18) . A duplicate filter containing B. pertussis, B. bronchiseptica, and B. parapertussis cell extracts was reacted with BB05 and gave results similar to those obtained with BPE3 (Fig. SB) . However, some additional bands were detected by BB05. Indirect immunofluorescence assays demonstrated that BPE3 recognizes a cell surface antigen on B. bronchiseptica ( Fig. 6C and D) as well as on B. pertussis ( Fig. 6A  and B) . However, no binding to B. parapertussis cells was observed ( Fig. 6E and F) . Five different B. bronchiseptica strains and three strains of B. parapertussis gave results similar to those shown in Fig. 5 for the appearance of a doublet band sometimes observed on SDS-PAGE. It is apparently an extrinsic outer membrane constituent, since it can be easily released from the surface of the bacteria by heating the cells for 60 min at 60°C. Also, it is a major constituent of bacterial preparations produced by mechanical shearing or by extracting the cells with 4 M urea (Brennan et al., unpublished data). Its electrophoretic mobility is not altered by heating, which suggests that it is not one of the B. pertussis heat-modifiable proteins that have been previously described (2) . The 69-kDa component was purified by affinity chromatography from extracts of B. pertussis BP353 and the nonagglutinating strains 114 and 165, and no apparent differences in electrophoretic mobility or immunologic reactivity were observed. Differences in migration on SDS-polyacrylamide gels were observed for the antigenically reactive bands found in extracts of B. bronchiseptica and B. parapertussis cells, which suggests that this protein is slightly different in these closely related Bordetella species.
The antigen defined here by the three anti-B. pertussis monoclonal antibodies was found to be antigenically similar to a protein first identified on B. bronchiseptica cells by a monoclonal antibody, BB05, raised against a B. bronchiseptica vaccine (18) . Monoclonal antibody BB05 recognizes an antigen on B. pertussis and B. parapertussis, as does BPE3, although slight differences in the number and sizes of the bands recognized by these antibodies were observed on Western blots. Also, BB05 binds to the surface of B. parapertussis cells (18) , whereas there is no evidence that BPE3 binds to these cells. BPE3 and BB05 recognize different epitopes, as determined by competitive inhibition studies (P. Novotny, unpublished data), which may account for these findings.
Previous evidence suggests that the 69-kDa protein is associated with the adenylate cyclase activity of Bordetella species (20) , and we have observed that all strains which produce adenylate cyclase also express the 69-kDa protein. However, they apparently are separate gene products, since transposon TnS insertion mutant BP348, which is defective in adenylate cyclase activity (29) , does contain the 69-kDa protein (Brennan et al., unpublished data). The monoclonal antibodies described here should be useful for investigating the relationship of the 69-kDa protein with the Bordetella adenylate cyclase toxin. There is evidence that this protein is also a protective antigen in animal models (21, 22) ; therefore, the monoclonal antibodies can be used in passive immunization studies to further assess its role as a protective antigen. The antibodies should also be useful for further structural and functional analysis of this protein and for establishing a better-defined serotyping system for B. pertussis. The finding that this protein can stimulate the production of agglutinating antibodies and the fact that it is a surface protein found on all virulent strains of B. pertussis suggest that it should be considered as a prospective acelluar vaccine candidate.
